Physician
Avera Mckennan
Avera Mckennan was paid $10.61M by Medicaid between Jan 2018 and Dec 2024, across 142 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 29% of everything it billed.
33Billing provider infoAVERA MCKENNAN
SIOUX FALLS, SD 57105
SIOUX FALLS, SD 57105
33aNPI1376575514assigned 07/07/2006
33bProvider typeSurgery Physician
28Total paid$10.61M
24GClaims371,449
24DCodes billed142
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Surgery Physician providers in South Dakota
Rank by total paid#2 of 10
Median peer was paid$6K
This provider vs. median1,733×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 48,170 | $1.30M | |
| 2019 | 47,181 | $1.29M | |
| 2020 | 26,368 | $770K | |
| 2021 | 50,127 | $1.48M | |
| 2022 | 59,765 | $1.68M | |
| 2023 | 65,262 | $1.73M | |
| 2024incomplete | 74,576 | $2.36M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 29% | 79,343 | 66,039 | $3.10M |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 19% | 37,231 | 32,715 | $2.01M |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | 7.3% | 11,901 | 10,668 | $772K |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | 5.8% | 9,399 | 9,078 | $620K |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | 3.7% | 5,988 | 5,736 | $396K |
| 90472 | Immunization administration, each additional vaccine (list separately) | 3.3% | 16,458 | 15,836 | $352K |
| 0241U | Neonatal screening for hereditary disorders, genomic sequence analysis panel | 2.8% | 2,760 | 2,562 | $295K |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | 2.4% | 3,845 | 3,644 | $255K |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | 2.2% | 23,192 | 22,105 | $229K |
| W0037 | 1.8% | 26,870 | 26,870 | $190K | |
| 99460 | 1.8% | 2,427 | 2,302 | $188K | |
| 99215 | Doctor's office visit, returning patient (complex)Prolong outpt/office vis | 1.6% | 2,279 | 2,069 | $175K |
130 more codes
| 99238 | Hospital discharge day management, 30 minutes or less | 1.4% | 2,741 | $152K |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | 1.4% | 5,439 | $150K |
| 54150 | 1.3% | 1,127 | $140K | |
| 99395 | Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years | <1% | 1,648 | $106K |
| 99222 | Initial hospital care, per day, moderate complexity | <1% | 1,078 | $97K |
| 0240U | <1% | 831 | $86K | |
| 99203 | Doctor's office visit, new patient (routine) | <1% | 1,290 | $79K |
| 99308 | Subsequent nursing facility care, per day, straightforward | <1% | 2,604 | $72K |
| 71046 | Radiologic examination, chest; 2 views | <1% | 3,147 | $62K |
| 90473 | <1% | 5,983 | $58K | |
| 99232 | Hospital visit by a doctor, follow-up day | <1% | 1,258 | $58K |
| 99462 | <1% | 1,544 | $51K | |
| 99309 | Subsequent nursing facility care, per day, low to moderate complexity | <1% | 1,486 | $48K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 1,051 | $46K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 1,893 | $46K |
| 99396 | Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years | <1% | 626 | $44K |
| 36415 | Collection of venous blood by venipuncture | <1% | 9,246 | $41K |
| 99204 | Doctor's office visit, new patient (more involved) | <1% | 411 | $41K |
| J1050 | Injection, medroxyprogesterone acetate, 1 mg | <1% | 956 | $37K |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | <1% | 508 | $36K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 3,758 | $34K |
| 90651 | <1% | 3,260 | $27K | |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | <1% | 607 | $25K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 3,975 | $24K |
| 99223 | Prolong inpt eval add15 m | <1% | 200 | $23K |
| 90686 | <1% | 10,907 | $23K | |
| 91322 | <1% | 226 | $22K | |
| 90715 | <1% | 2,334 | $20K | |
| 17110 | <1% | 235 | $18K | |
| 0001A | <1% | 559 | $17K | |
| 99383 | <1% | 184 | $17K | |
| 0002A | <1% | 504 | $17K | |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 1,270 | $16K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | <1% | 249 | $15K |
| 74018 | <1% | 783 | $14K | |
| 80050 | General health panel | <1% | 532 | $14K |
| 90480 | <1% | 553 | $14K | |
| 80053 | Comprehensive metabolic panel | <1% | 1,580 | $13K |
| 87631 | <1% | 99 | $13K | |
| 80061 | Lipid panel | <1% | 1,157 | $12K |
| 0071A | <1% | 276 | $10K | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 1,263 | $10K |
| 90837 | Psychotherapy session, about an hour | <1% | 92 | $9K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 699 | $9K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 386 | $8K |
| 77067 | Screening mammography, bilateral, including computer-aided detection | <1% | 148 | $8K |
| 99384 | <1% | 99 | $8K | |
| 0072A | <1% | 196 | $7K | |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | <1% | 124 | $6K |
| 81001 | <1% | 2,407 | $6K | |
| 90656 | <1% | 1,126 | $6K | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 587 | $5K |
| 84439 | <1% | 780 | $5K | |
| 87634 | <1% | 92 | $5K | |
| 0124A | <1% | 184 | $5K | |
| 90670 | <1% | 6,879 | $5K | |
| 0081A | <1% | 167 | $5K | |
| 90677 | <1% | 56 | $4K | |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 642 | $4K |
| 90671 | <1% | 2,103 | $4K | |
| 81025 | <1% | 593 | $4K | |
| 85027 | <1% | 789 | $4K | |
| 77063 | Screening digital breast tomosynthesis, bilateral | <1% | 136 | $4K |
| G2211 | Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) | <1% | 5,130 | $4K |
| 87510 | <1% | 247 | $3K | |
| 87660 | <1% | 249 | $3K | |
| 87480 | <1% | 244 | $3K | |
| 74019 | <1% | 183 | $3K | |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 465 | $3K |
| 90620 | <1% | 299 | $3K | |
| 90734 | <1% | 2,286 | $3K | |
| 93010 | Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | <1% | 536 | $3K |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 453 | $3K |
| 90716 | <1% | 2,336 | $2K | |
| 90707 | <1% | 2,319 | $2K | |
| 90750 | <1% | 12 | $2K | |
| 99188 | <1% | 78 | $2K | |
| 0054A | <1% | 87 | $2K | |
| 99382 | <1% | 28 | $2K | |
| 0082A | <1% | 47 | $2K | |
| 73630 | <1% | 87 | $2K | |
| 99239 | Hospital discharge day management, more than 30 minutes | <1% | 20 | $1K |
| 96381 | <1% | 214 | $1K | |
| 83550 | <1% | 188 | $1K | |
| 73610 | <1% | 75 | $1K | |
| 99307 | <1% | 58 | $1K | |
| 0004A | <1% | 59 | $1K | |
| 83540 | <1% | 206 | $1K | |
| 87807 | <1% | 73 | $1K | |
| 0074A | <1% | 26 | $1K | |
| 99221 | <1% | 12 | $987.67 | |
| 87210 | <1% | 225 | $985.77 | |
| 99417 | Prolong home eval add 15m | <1% | 31 | $852.06 |
| 0154A | <1% | 24 | $704.36 | |
| 99231 | Subsequent hospital care, per day, straightforward or low complexity | <1% | 19 | $675.29 |
| 36416 | <1% | 1,518 | $635.34 | |
| 0051A | <1% | 25 | $595.05 | |
| 0003A | <1% | 16 | $555.38 | |
| 0052A | <1% | 16 | $555.38 | |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | <1% | 16 | $529.95 |
| 0053A | <1% | 13 | $468.26 | |
| 91321 | <1% | 217 | $437.76 | |
| 99442 | <1% | 42 | $406.59 | |
| 69209 | <1% | 32 | $386.98 | |
| 85018 | <1% | 126 | $232.26 | |
| 90633 | <1% | 4,944 | $167.20 | |
| 90710 | <1% | 2,108 | $63.70 | |
| 85651 | <1% | 12 | $51.24 | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 35 | $49.68 |
| 96161 | <1% | 12 | $43.50 | |
| 90685 | <1% | 168 | $23.64 | |
| J7613 | Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg | <1% | 50 | $4.85 |
| 90696 | <1% | 1,859 | $0.31 | |
| 90461 | 0% | 71 | $0.00 | |
| 90672 | 0% | 15 | $0.00 | |
| 90700 | 0% | 2,277 | $0.00 | |
| 90648 | 0% | 7,151 | $0.00 | |
| 90713 | 0% | 19 | $0.00 | |
| 91300 | 0% | 1,097 | $0.00 | |
| 90661 | 0% | 81 | $0.00 | |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | 0% | 114 | $0.00 |
| 90687 | 0% | 17 | $0.00 | |
| 90380 | 0% | 55 | $0.00 | |
| 90723 | 0% | 5,214 | $0.00 | |
| 90680 | 0% | 5,838 | $0.00 | |
| 90697 | 0% | 1,563 | $0.00 | |
| 91307 | 0% | 447 | $0.00 | |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 0% | 221 | $0.00 |
| 91305 | 0% | 254 | $0.00 | |
| 90381 | 0% | 134 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialNORTON, JULIE (SR. VICE PRESIDENT OF FINANCE)
| Provider | Location | Paid |
|---|---|---|
| Avera Mckennan | Flandreau, SD | $394K |
| Avera Mckennan | Worthington, MN | $332K |
| Avera Mckennan | Sibley, IA | $159K |
| Avera Mckennan | Dell Rapids, SD | $141K |
| Avera Mckennan | Winner, SD | $139K |
| Brookings Health System/Avera Home Medical Equipment LLC | Brookings, SD | $50K |
| Avera Mckennan | Miller, SD | $9K |
| Avera Mckennan | Chamberlain, SD | $3K |
| Avera Mckennan | Big Stone City, SD | $815.32 |
| Avera Mckennan | Larchwood, IA | $464.26 |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.